© 2022 MJH Life Sciences and Nutritional Outlook. All rights reserved.
© 2022 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
October 18, 2022
The companies will work jointly on the development and distribution of a clinically-backed collagen product that is manufactured from premium ling maw supplied by NZCS.
October 17, 2022
Called bio+Quercitrin, the ingredient is said to be up to six times more bioavailable than standard quercetin.
Bioactive collagen peptides Fortigel from Gelita has been authorized by the National Health Agency (Anvisa) in Brazil to carry the claim “may contribute to the maintenance of joint health.”
October 05, 2022
Vedic Lifesciences, a contract research organization based, has completed a randomized, controlled dose response study for Interpath Pty Ltd. on its patented ingredient called Epiitalis.
September 21, 2022
An influx of next-generation ingredients and a growing consumer need are driving joint health supplements to new heights.
September 06, 2022
As consumers get active post-pandemic, they’ll find a wider range of sports supplements ready to cater to their every need.
September 02, 2022
The CRN Foundation has published a new economic report which analyzes the potential healthcare cost savings that could be realized if at-risk populations used specific dietary supplements as a form of preventative healthcare.
August 17, 2022
Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.
August 16, 2022
The new Laboratory Guidance Document provides an evaluation of 46 analytical methods and their suitability to authenticate Boswellia serrata oleogum resin and its extracts.
August 15, 2022
ChenlandNutritionals’ ingredient CuminUP60 is now self-affirmed GRAS (generally recognized as safe) with assistance from GRAS Associates, a fully owned subsidiary of Nutrasource